Comparative Cardioprotective Effect of Herbs of Hridya dashemani (Karamarda- Carissa carandas L., Badara- Ziziphus jujuba Lam.) versus Arjuna-Terminalia arjuna (Roxb.ex.DC.) Wight & Arn. against Isoprenaline induced Myocardial Infarction in Rats
Abstract
Hridya dashemani, (ten cardioprotective herbs) includes fruits of Amra, Amrataka, Lakucha, Karamarda, Vrukshamla, Amlavetasa, Kuvala, Badara, Dadima and Matulunga. In Ayurveda, these herbs have been known to be conducive to heart. The present study was designed to evaluate the cardioprotective action of two herbs of Hridya dashemani [fruits of Karamarda (Carissa carandas L.) and fruits of Badara (Ziziphus jujuba Lam.)] on the basis of biochemical & histopathological parameters in isoprenaline (ISO) induced myocardial infarction (MI) in experimental rats and to compare with stem bark of Arjuna (Terminalia arjuna (Roxb.ex.DC.) Wight & Arn.), a well-known cardioprotective herb. Thirty-six male wistar albino rats were randomly divided into six groups. Group I- Normal control (NC), Group II- ISO induced MI, Group III- Positive control with Hesperidin (100mg/kg b.w), Group IV- Badara (Z. jujuba - 450mg/kg b.w), Group V-Karamarda (C. carandus - 450mg/kg b.w), Group VI-Arjuna (T.arjuna - 450mg/kg b.w). After 21 days of pre-treatment, experimental MI was induced in all groups except NC by injecting ISO subcutaneously (85 mg/kg) on 19th & 20th day at an interval of 24 hr. Serum biochemical parameters including cardiac biomarkers and histopathological examination of heart tissues were evaluated. ISO treated rats had a significant (P < 0.05) elevation in serum levels of diagnostic marker enzymes (AST, ALT, CK-MB, LDH, ALP) when compared to NC. All the pre-treated groups had significantly (P < 0.05) reduced serum levels of marker enzymes when compared to ISO treated control. The protective role of these herbs was further confirmed by histopathological examination. Comparison revealed that Karamarda (C. carandus) pre-treated had similar protective effect as Arjuna (T. arjuna) in various biochemical parameters (AST, ALT, ALP, LDH, CK-MB, HDL, Cholesterol, Creatinine). It may be concluded from the present study that 450mg/kg b.w of water extract of the above herbs have cardioprotective action against isoprenaline induced MI, with Karamarda (C. carandus) & Arjuna (T. arjuna) having almost similar effects. The study paves way to further evaluate these herbs as preventive and curative in the clinical management of cardiovascular disease (CVD).
Keywords:
Cardioprotection, Carissa carandas Linn. Mant., Ziziphus jujuba Lam., Terminalia arjuna (Roxb.ex.DC.) Wight & Arn., Isoprenaline, Myocardial infarction, HridyadashemaniDOI
https://doi.org/10.25004/IJPSDR.2023.150313References
Cardiovascular diseases (CVDs)[Internet].[cited 2023 May 13]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Non-communicable diseases India 2018 country profile[Internet]. [cited 2023 May 13]. Available from: https://www.who.int/publications/m/item/noncommunicable-diseases-ind-countryprofile-2018
Jadavaji Trikamji Acharya, editor. Charaka Samhita. 5th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 2001. 32 p.
Sujatha G, Swarupa Rani G. Pharmacological Review on Hridya Dasaimani in the Management of Hridroga (cardiovascular diseases). International Journal of Ayurvedic Medicine. 2019;11(4S):41-44. Available from: https://www.ijam.co.in/index.php/ijam/article/view/1509
Gunathilaka LMTID, Kulatunga WMSSK. Therapeutic Potentials of Hridaya Dashakaya (Cardio Friendly Drugs) in Cardio Vascular Diseases - A Review. Asian Journal of Cardiology Research. 2021; 4(1): 236-247. Available from: https://journalajcr.com/index.php/AJCR/article/view/60
Goyal C, Malik A, Malik S, Kaur R. Literary review on Hridya Mahakasahya w.s.r. to their Cardio-protective action. Int J Green Herb Chem. 2021 Nov 30;10(4). Available from: doi.org/10.24214/IJGHC/HC/10/4/35160
Deshpande NM, Deshpande MM. Charakokta Hrudya Mahakashay - A Review. International Journal of Health Sciences & Research 2019;9(6): 333-344. Available from: https://www.ijhsr.org/IJHSR_Vol.9_Issue.6_June2019/48.pdf
Jadavaji Trikamji Acharya, editor.Charaka Samhita. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. 603 p.
Misra BS, editor. Bhavaprakasha Nighantu. Vol. 1. 7th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1990. 523 p.
Maulik SK, Katiyar CK. Terminalia arjuna in cardiovascular diseases: Making the Transition from Traditional to Modern Medicine in India. Curr Pharm Biotechnol. 2010 Dec 1;11(8):855–60. Available from: doi.org/10.2174/138920110793262051
Maulik SK, Talwar KK. Therapeutic Potential of Terminalia arjuna in Cardiovascular Disorders: Am J Cardiovasc Drugs.2012 Jun;12(3):157–63. Available from: doi.org/10.2165/11598990-000000000-00000
Sivakumar V, Rajeshkumar S. Screening of cardioprotective effect of Terminalia arjuna Linn. bark in isoproterenol - Induced myocardial infarction in experimental animals. International Journal of Pharma Sciences and Research. 2014;5(06):7. Available from: http://www.ijpsr.info/docs/IJPSR14-05-06-004.pdf
Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J. Sep-Oct 1997; 49(5): 507-10. Available from: https://pubmed.ncbi.nlm.nih.gov/9505018/
Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int J Cardiol. 1995 May; 49(3):191–9. Available from: doi.org/10.1016/0167-5273(95)02320-v
Anonymous. The Ayurvedic Pharmacopeia of India. 1st ed. Part I, Vol 3. New Delhi: Ministry of Health & Family Welfare, Department of AYUSH, Government of India; 2001. 95 p.
Pandey G, Dravyaguna vijnana. 1 ed.Part II. Varnasi: Chowkhamna Krishnadas Academy;2004.126
Gupta AK, Tandon N, Sharma M, editors. Quality standards of Indian medicinal plants. 1st ed. Vol. 2. New Delhi: Indian Council of Medical Research; 2005. 251 p.
Vogel H. Gerhard. Drug Discovery and Evaluation. 2nd ed. New York: Springer;2002.191
Khaliq F, Fahim M. Role of Terminalia arjuna in Improving Cardiovascular Functions: A Review. Indian J Physiol Pharmacol. 2018; 62(1): 8–19. Available from: https://ijpp.com/IJPP%20 archives/2018_62_1/8-19.pdf
Dwivedi S, Chopra D. Revisiting Terminalia arjuna – An Ancient Cardiovascular Drug. J Tradit Complement Med. 2014 Oct 1;4(4):224–31. Available from: doi.org/10.4103/2225-4110.139103
Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India. 1994 Apr;42(4):287-9. https://pubmed.ncbi.nlm.nih.gov/7741874/
Zanwar AA, Badole SL, Shende PS, Hegde MV, Bodhankar SL. Cardiovascular Effects of Hesperidin. In: Watson R R, Preedy R V, Zibadi S, editors. Polyphenols in Human Health and Disease. London: Academic Press, 2014; 989–92. Available from: doi.org/10.1016/B978-0-12-398456-2.00076-1
Selvaraj P, Pugalendi KV. Hesperidin, a flavanone glycoside, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats. Redox Rep. 2010 Oct; 15(5):217. Avaialble from: doi.org/10.1179/135100010X12826446921509
Li X, Hu X, Wang J, Xu W, Yi C, Ma R, et al. Short-Term Hesperidin Pretreatment Attenuates Rat Myocardial Ischemia/Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein Expression via the PI3K/Akt Pathway. Cell Physiol Biochem. 2016; 39(5):1850–62. Available from: doi.org/10.1159/000447884
Shukla SK, Sharma SB, Singh UR. β-Adrenoreceptor Agonist Isoproterenol Alters Oxidative Status, Inflammatory Signaling, Injury Markers and Apoptotic Cell Death in Myocardium of Rats. Indian J Clin Biochem. 2015 Jan; 30(1):27–34. Available from: doi.org/ 10.1007/s12291-013-0401-5
Li M, Jiang Y, Jing W, Sun B, Miao C, Ren L. Quercetin provides greater cardioprotective effect than its glycoside derivative rutin on isoproterenol-induced cardiac fibrosis in the rat. Can J Physiol Pharmacol. 2013 Nov; (11):951–9. Available from: doi.org/10.1139/cjpp-2012-0432
Mundugaru R, Udaykumar P, Senthilkumar S, Bhat S. Cardioprotective activity of fruit of Garcinia pedunculata on isoprenaline-induced myocardial infarction in rat. Bangladesh J Pharmacol. 2016;11(1):231–5. Available from: doi.org/10.3329/bjp.v11i1.24941
Choi KM, Han K, Park S, Chung HS, Kim NH, Yoo HJ, et al. Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study. Sci Rep. 2018 Dec;8(1):3764. Available from: doi.org/10.1038/s41598-018-19700-8
Ndrepepa G. Aspartate aminotransferase and cardiovascular disease—a narrative review. J Lab Precis Med. 2021 Jan;6:6–6. Available from: doi.org/10.21037/jlpm-20-93
Nigam PK. Biochemical markers of myocardial injury. Indian J Clin Biochem. 2007;22(1):10-17. Available from: doi.org/10.1007/BF02912874
Al-Hadi HA, Fox KA. Cardiac Markers in the Early Diagnosis and Management of Patients with Acute Coronary Syndrome. Sultan Qaboos Univ Med J. 2009 Dec; 9(3):231–46. Available from: https://journals.squ.edu.om/index.php/squmj/article/view/1435
Shukla SK, Sharma SB, Singh UR, Ahmad S, Dwivedi S. Terminalia arjuna (Roxb.) Wight & Arn. augments cardioprotection via antioxidant and antiapoptotic cascade in isoproterenol induced cardiotoxicity in rats. Indian J Exp Biol. 2015;9. Available from: http://nopr.niscpr.res.in/bitstream/123456789/33462/1/IJEB%2053%2812%29%20810-818.pdf
Shan SW. Strategic Utilization of Cardiac Markers for the Diagnosis of Acute Myocardial Infarction. Annals Clin Lab Sci. 1996;26(4): 301-12. Available from: http://www.annclinlabsci.org/content/26/4/301.full.pdf
Li JW, Xu C, Fan Y, Wang Y, Xiao YB. Can Serum Levels of Alkaline Phosphatase and Phosphate Predict Cardiovascular Diseases and Total Mortalit y in Individuals with Preserved Renal Function? A Systemic Review and Meta-Analysis. PLOS ONE. 2014 Jul; 9(7):e102276. Available from: doi.org/10.1371/journal.pone.0102276
Ndrepepa G. Alkaline phosphatase and cardiovascular disease. J Lab Precis Med. 2017 Oct; 2:83–83. Available from: http://jlpm.amegroups.com/article/view/3864/4630
Boullart ACI, de Graaf J, Stalenhoef AF. Serum triglycerides and risk of cardiovascular disease. Biochim Biophys Acta BBA – Mol Cell Biol Lipids. 2012 May; 1821(5):867–75. Available from: doi.org/10.1016/j.bbalip.2011.10.002
Siddiqi HK, Kiss D, Rader D. HDL-cholesterol and cardiovascular disease: rethinking our approach. Curr Opin Cardiol. 2015 Sep; 30(5):536–42. Available from: doi.org/10.1097/HCO.0000000000000211
Wannamethee SG, Shaper AG, Perry IJ. Serum Creatinine Concentration and Risk of Cardiovascular Disease. Stroke. 1997 Mar; 28(3):557–63. Available from: doi.org/10.1161/01.str.28.3.557
Jain S, Buttar HS, Chintameneni M, Kaur G. Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies. Recent Pat Inflamm Allergy Drug Discov. 2018 Sep 11;12(2):145–57. Available from: doi.org/10.2174/1872213X12666180815144803
Amalraj A, Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review. J Tradit Complement Med. 2017 Jan;7(1):65–78. Available from: doi.org/10.1016/j.jtcme.2016.02.003
Priscilla DH, Prince PSM. Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Chem Biol Interact. 2009 May;179(2–3):118–24. Available from: doi.org/10.1016/j.cbi.2008.12.012
Prakash O, Usmani S, Singh R, Singh N, Gupta A, Ved A. A panoramic view on phytochemical, nutritional, and therapeutic attributes of Ziziphus mauritiana Lam.: A comprehensive review. Phytother Res. 2021 Jan; 35(1):63–77. Available from: doi.org/10.1002/ptr.6769
Cook NC, Samman S. Flavonoids—Chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 1996 Feb 1; 7(2):66–76. Available from: doi.org/10.1016/S0955-2863(95)00168-9
Cheng D, Zhu C, Cao J, Jiang W. The protective effects of polyphenols from jujuba peel (Ziziphus jujuba Mill) on isoproterenol-induced myocardial ischemia and aluminum-induced oxidative damage in rats. Food Chem Toxicol. 2012 May; 50(5):1302–8. Available from: doi.org/10.1016/j.fct.2012.01.026
Singh S, Bajpai M, Mishra P. Carissa carandas L. – phytopharmacological review. J Pharm Pharmacol 2020 Nov;72(12):1694– 714. Available from: doi.org/10.1111/jphp.13328
Published
Abstract Display: 635 
PDF Downloads: 413 How to Cite
Issue
Section
Copyright (c) 2023 Harini A Rao, Veena M S, Lalitha B R, Sudhakara Bhat
This work is licensed under a Creative Commons Attribution 4.0 International License.
